Bicycle Therapeutics PLC (BCYC)
14.00
-0.13
(-0.92%)
USD |
NASDAQ |
Dec 31, 16:00
14.27
+0.27
(+1.93%)
After-Hours: 20:00
Bicycle Therapeutics Cash from Investing (Quarterly): -0.435M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics PLC | -9.589M |
| TC BioPharm (Holdings) PLC | -0.0379M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Mereo BioPharma Group PLC | 0.00 |
| Verona Pharma PLC | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.83M |
| Cash from Financing (Quarterly) | -31.93M |
| Free Cash Flow | -203.53M |
| Free Cash Flow Per Share (Quarterly) | -0.5837 |
| Free Cash Flow to Equity (Quarterly) | -9.358M |
| Free Cash Flow to Firm (Quarterly) | -40.27M |
| Free Cash Flow Yield | -28.22% |